Core Insights - Philip Morris International Inc. reported fourth-quarter results that met analyst expectations, with adjusted earnings per share of $1.70 and revenue of $10.4 billion, slightly above the expected $10.39 billion [1] Group 1: Financial Performance - The company achieved adjusted diluted EPS of $7.54 for the full year 2025, reflecting a year-over-year growth of 14.8%, or 14.2% on a currency-neutral basis [2] - Revenue from smoke-free products constituted 41.5% of total net revenues and nearly 43% of total gross profit, marking increases of 2.8 and 3.2 percentage points compared to full-year 2024 [3] Group 2: Business Growth and Strategy - Smoke-free shipment volumes increased by 8.5% in the quarter, while traditional cigarette volumes saw a decline of 2.2% [2] - Philip Morris guided for fiscal 2026 adjusted EPS in the range of $8.38 to $8.53, surpassing the analyst consensus of $8.33 [4] - The company set new growth targets for 2026–2028, aiming for organic net revenue growth of 6% to 8%, organic operating income growth of 8% to 10%, and adjusted diluted EPS growth of 9% to 11%, excluding currency effects [4]

Core Insights - Philip Morris International Inc. reported an earnings per share (EPS) of $1.70, matching estimates, but revenue of $10.36 billion slightly missed expectations of $10.40 billion [1][6] - The company has achieved its fifth consecutive year of volume growth, with net revenues exceeding $40 billion in 2025, of which nearly $17 billion came from its smoke-free business [2][6] - Despite a decline in stock price due to softer-than-expected revenue figures, the company's strong performance and strategic focus on smoke-free products position it well for future success [3][6] Financial Metrics - The price-to-earnings (P/E) ratio of Philip Morris is approximately 32.90, with a price-to-sales ratio of about 7.09 and an enterprise value to sales ratio of 8.25, indicating market valuation of its earnings and sales [4] - The company's earnings yield stands at around 3.04%, reflecting its profitability relative to its stock price [4] - Philip Morris has a debt-to-equity ratio of -4.59, indicating a significant level of debt compared to equity, and a current ratio of 0.85, suggesting its ability to cover short-term liabilities with short-term assets [5]

Philip Morris International Inc. (NYSE:PM) stock rose Friday after the company reported fourth-quarter fiscal 2025 results.The company pointed to strong smoke-free momentum and a record Marlboro share while outlining upbeat earnings and growth targets.Quarterly MetricsPhilip Morris reported fourth-quarter adjusted earnings per share of $1.70, in line with the Street view. Quarterly sales of $10.362 billion (+6.8% year over year) missed the Street view of $10.440 billion.“We achieved another remarkable year ...

Key Takeaways PM posted adjusted EPS of $1.70, up 9.7% Y/Y, beating estimates despite revenues missing expectations.Smoke-free revenues rose 12% and accounted for over half of net revenues in three of four regions.Net revenues climbed 6.8% as pricing strength and smoke-free volumes offset lower cigarette shipments.Philip Morris International Inc. (PM) reported fourth-quarter 2025 results, with both top and bottom lines increasing year over year. Net sales missed the Zacks Consensus Estimate, while earnings ...

Market Analysis by covering: Biogen Inc, Philip Morris International Inc, Centene Corp. Read 's Market Analysis on Investing.com ...

We accomplished this through strong pricing, portfolio resilience, and disciplined execution, with Marlborough reaching a historic high share. Managing this business responsibly enables us to invest boldly in better alternatives and sustain our smoke-free momentum. Together, these factors enabled us to deliver 15% adjusted diluted EPS growth in dollar terms, the strongest growth since 2011, excluding the pandemic recovery year of 2021. This reflects currency-neutral growth of 14% well above our expectations ...

Philip Morris (PM) reported $10.36 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 6.8%. EPS of $1.70 for the same period compares to $1.55 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $10.43 billion, representing a surprise of -0.63%. The company delivered an EPS surprise of +2.04%, with the consensus EPS estimate being $1.67.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- an ...

Philip Morris International (NYSE:PM) Q4 2025 Earnings call February 06, 2026 09:00 AM ET Company ParticipantsEmmanuel Babeau - CFOEric Serotta - Executive Director for US Beverages, Tobacco, and Household ProductsJacek Olczak - Group CEOJames Bushnell - VP of Investor Relations and Financial CommunicationConference Call ParticipantsBonnie Herzog - Managing Director and Veteran AnalystDamian McNeela - Director and Senior Analyst of Consumer StaplesFaham Baig - Global Tobacco Analyst and Executive DirectorGe ...

Philip Morris International (NYSE:PM) Q4 2025 Earnings call February 06, 2026 09:00 AM ET Company ParticipantsEmmanuel Babeau - CFOJacek Olczak - Group CEOJames Bushnell - VP of Investor Relations and Financial CommunicationConference Call ParticipantsGerald Pascarelli - Senior Analyst of Beverages, Tobacco, and CannabisMatt Smith - Senior Analyst of Consumer StaplesOperatorday and thank you for standing by. Welcome to the Philip Morris International, Inc., 2025 fourth quarter results conference call. At th ...

Financial Data and Key Metrics Changes - In 2025, total net revenues exceeded $40 billion, with 41.5% or nearly $17 billion generated from smoke-free products [8][11] - Adjusted diluted EPS grew by 15% in dollar terms, marking the strongest growth since 2011, excluding the pandemic recovery year of 2021 [5][11] - Organic top-line growth was +6.5%, with adjusted operating income growth at +10.6%, reflecting +140 basis points of organic margin expansion [11][12] Business Line Data and Key Metrics Changes - Smoke-free product volumes grew by 12.8%, with organic smoke-free gross profit growth of 18.7% [3][12] - IQOS shipments grew by approximately 11%, with a notable acceleration in the fourth quarter [3][15] - ZYN shipments in the U.S. increased by 37%, contributing significantly to smoke-free product growth [5][14] Market Data and Key Metrics Changes - The international business generated the majority of total PMI organic net revenue growth, with smoke-free products leading the way [5][19] - In Japan, the heat-not-burn category surpassed 50% of total industry volumes, driven by IQOS [25][26] - The U.S. market for nicotine pouches saw ZYN capturing around 50% of category growth, with a volume share of 61.5% [30][22] Company Strategy and Development Direction - The company continues to focus on a multi-category strategy, expanding its smoke-free product offerings and geographic reach [4][9] - There is a strong emphasis on innovation and digitalization to support long-term growth [9][43] - The company targets a leverage ratio of close to 2x by the end of 2026, indicating a focus on financial flexibility and shareholder returns [7][44] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving strong growth despite transitory headwinds, with a forecast of 5%-7% organic net revenue growth for 2026 [36][37] - The company anticipates continued strong cash generation, with operating cash flow projected at around $13.5 billion [38][43] - Management highlighted the importance of navigating regulatory environments and enhancing brand equity for future growth [32][33] Other Important Information - The company achieved a historic high share for Marlboro, reaching 11% of the international category, excluding China [34][5] - The number of legal-age consumers of smoke-free products reached an estimated 43.5 million, reflecting broad-based growth across categories [20][19] - The company is committed to delivering superior shareholder value, with a target dividend payout ratio of around 75% of adjusted diluted EPS [44][45] Q&A Session Summary Question: Can you expand on the reacceleration in smoke-free volume growth compared to the 2026 growth guidance? - Management indicated that the acceleration is expected due to tax changes in Japan and competitive dynamics in the U.S. market [49][50] Question: How are you thinking in terms of IQOS, HTU shipments, and IMS for 2026? - Management noted that while Japan faces challenges, other markets like Italy and Germany are showing strong growth, contributing positively to IQOS's outlook [58][62] Question: What are the key growth drivers for the upcoming year? - Management emphasized the importance of ZYN and IQOS, along with ongoing investments in marketing and innovation, as key drivers for growth [72][75]